Disclaimer
Regulatory status
ALGINAGRAFT™ is a bone graft technology under development by Meddent Innovative Concepts. It has not been cleared or approved by the U.S. Food and Drug Administration or any other regulatory authority, has not been evaluated in clinical studies, and is not available for sale or clinical use in any jurisdiction. Nothing on this website is an offer to sell, or a solicitation of an offer to buy, any product.
Development objectives, not performance claims
Statements on this website about design objectives, intended handling, potential applications, configurations and future directions describe development goals only. They are not representations of regulatory clearance, approval, safety, effectiveness or clinical performance. No bench, preclinical or clinical data for ALGINAGRAFT™ have been published. Where this website reports results from the scientific literature, those results concern other materials and studies, are cited to their source, and are not evidence for ALGINAGRAFT™.
Intended audience; not medical advice
This website is intended for licensed dental and medical professionals in the United States. It does not constitute medical, dental or professional advice and does not create a clinician–patient relationship. Clinical decisions must rest on the clinician's own judgement, the applicable standard of care and the labelling of legally marketed products. Patients should consult a licensed clinician.
Accuracy and sources
The publisher takes care that figures on this website are drawn from public registries, audited filings and peer-reviewed literature and are cited to their source and date of retrieval. Registries and literature change; a figure is accurate as of the date stated next to it. The editorial policy explains how sources are selected and how corrections are made. The publisher makes no warranty, express or implied, as to completeness or fitness for any purpose.
Patents and trademark
The alginate-based composition described on this website is the subject of pending U.S. Patent Application No. 18/831,819, published as US 2026/0053599 A1. Patent pending. A pending application confers no enforceable rights until a patent is granted. Granted patents held by the inventor are listed on the patents page with their full titles and registry links; that page constitutes the virtual patent marking under 35 U.S.C. § 287(a) for the products it identifies. ALGINAGRAFT™ is a trademark of Igor Roshkovan; U.S. trademark applications Serial Nos. 97564474 and 97564486 are pending, and the mark is not registered.
Photographs
Intraoperative photographs on this website show conventional bone augmentation procedures performed by Dr. Igor Roshkovan. They do not depict ALGINAGRAFT™, and no photograph shows a face or other feature that identifies a patient. Photographs are the property of the author and may not be reproduced without permission.
Third-party content and links
Links to registries, journals, companies and other websites are provided for reference. The publisher does not control those sites and is not responsible for their content or availability. Product names and trademarks of other companies belong to their owners; their mention does not imply endorsement in either direction.
Forward-looking statements
Statements about future development steps, testing, regulatory submissions or evaluations are expectations, not commitments. They depend on results that do not yet exist and may not occur, or may occur later or differently than described. The development status page is updated when a step is completed, with its date.
Contact
Questions about this disclaimer may be sent through the contact page.